» Articles » PMID: 36600194

Mortality in Hemodialysis Patients in Ethiopia: a Retrospective Follow-up Study in Three Centers

Overview
Journal BMC Nephrol
Publisher Biomed Central
Specialty Nephrology
Date 2023 Jan 4
PMID 36600194
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prevalence of chronic kidney disease (CKD) is between 10 and 15% worldwide. Ethiopia is seeing a consistent increase in the number of dialysis patients. Patients on chronic hemodialysis have high mortality rates, but there is little information available in Ethiopia. Thus, this study looked into patient mortality and the factors that contributed to it at three dialysis centers in Addis Ababa for hemodialysis patients.

Method: A facility-based retrospective follow-up study was employed among End-Stage Renal Disease patients on hemodialysis from 2016 to 2020 at St. Paul Millennium Medical College (SPMMC), Zewditu Memorial Hospital (ZMH), and Menelik II Hospital. The proportional hazard assumption was checked by using the Log (-log (St)) plots and tests. Life-table analysis was fitted to estimate the one and five-year's survival probability of these patients and Cox Proportional regression analysis to model the predictors of mortality at p-value < 0.05.

Result: Over the course of 2772 person-months, 139 patients were tracked. Of these patients, 88 (63.3%) were male and the mean age (± SD) of the patients was 36.8 (± 11.9) years. During the follow-up period, 24 (17%) of the patients died, 67 (48.2%) were alive, 43 (30.9%) received a kidney transplant, and 5 (3.6%) were lost to follow-up. The mean survival time was 46.2 months (95% CI: 41.8, 50.5). According to estimates, there were 104 deaths per 1000 person-years at the end of the follow-up period. The likelihood that these patients would survive for one and 5 years was 91%% and 65%, respectively. Our analysis showed that patients with hypertension (Adjusted Hazard Rate (AHR) = 4.33; 95% CI: 1.02, 34.56), cardiovascular disease (AHR = 4.69; 95% CI: 1.32, 16.80), and infection during dialysis (AHR = 3.89; 95% CI: 1.96, 13.80) were more likely to die.

Conclusion: The hemodialysis patients' death rate in the chosen dialysis facilities was high. Preventing and treating comorbidities and complications during dialysis would probably reduce the mortality of CKD patients. Furthermore, the best way to avoid and manage chronic kidney disease is to take a complete and integrated approach to manage hypertension, diabetes, and obesity.

Citing Articles

Clinical characteristics and outcomes of patients on haemodialysis at Jimma medical center, Ethiopia: a 7-Year review.

Tafese S, Abera E, Mersha M, Woldemariam M BMC Nephrol. 2024; 25(1):420.

PMID: 39578801 PMC: 11583399. DOI: 10.1186/s12882-024-03860-z.


Incidence and predictors of acute kidney injury among adults admitted to the medical intensive care unit of a Comprehensive Specialized Hospital in Central Ethiopia.

Ashine T, Mekonnen M, Heliso A, Wolde Y, Babore G, Bushen Z PLoS One. 2024; 19(6):e0304006.

PMID: 38924008 PMC: 11207181. DOI: 10.1371/journal.pone.0304006.


Nephrotoxic drug burden and predictors of exposure among patients with renal impairment in Ethiopia: A multi-center study.

Zeleke T, Kemal L, Mehari E, Sema F, Seid A, Mekonnen G Heliyon. 2024; 10(2):e24618.

PMID: 38298684 PMC: 10828699. DOI: 10.1016/j.heliyon.2024.e24618.


Access- and non-access-related infections among patients receiving haemodialysis: Experience of an academic centre in Oman.

Himali N, Abdelrahman A, Al Suleimani Y, Balkhair A, Al-Zakwani I IJID Reg. 2023; 7:252-255.

PMID: 37215397 PMC: 10193159. DOI: 10.1016/j.ijregi.2023.04.005.

References
1.
De Clerck D, Bonkain F, Cools W, Van der Niepen P . Vascular access type and mortality in haemodialysis: a retrospective cohort study. BMC Nephrol. 2020; 21(1):231. PMC: 7302381. DOI: 10.1186/s12882-020-01889-4. View

2.
de Lima J, Sesso R, Abensur H, Lopes H, Giorgi M, Krieger E . Predictors of mortality in long-term haemodialysis patients with a low prevalence of comorbid conditions. Nephrol Dial Transplant. 1995; 10(9):1708-13. View

3.
Rezapour M, Taran S, Balin Parast M, Khavanin Zadeh M . The impact of vascular diameter ratio on hemodialysis maturation time: Evidence from data mining approaches and thermodynamics law. Med J Islam Repub Iran. 2016; 30:359. PMC: 4934486. View

4.
Mickey R, Greenland S . The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989; 129(1):125-37. DOI: 10.1093/oxfordjournals.aje.a115101. View

5.
Kim D, Park J, Lee J, Kim Y, Kang S, Yang C . The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients. Ren Fail. 2019; 42(1):30-39. PMC: 6968432. DOI: 10.1080/0886022X.2019.1702558. View